-
Management attributed the 7.4% quarter-over-quarter NAV decline almost entirely to unrealized mark-to-market adjustments in specific equity positions rather than realized credit losses.
-
The core first lien portfolio, representing approximately 81% of investments, showed improved health with weighted average interest coverage rising from 1.94x to 2.6x.
-
Management highlighted an intentional strategic avoidance of the software sector, which stands at only 1.8% of the portfolio, citing an unwillingness to lend against negative EBITDA profiles and ARR-based methodologies.
-
The company maintained a selective investment approach, passing on a historically high percentage of new deals due to aggressive market pricing and looser credit documentation driven by record private debt fundraising.
-
Nonaccruals remained essentially flat at 1.78% of the portfolio at fair value, with management stating they are not seeing the ‘material cracks’ in private credit reported by the press.
-
Strategic PIK income is primarily derived from structured first lien investments by design, representing approximately 75% of total PIK investments, with 73% of PIK investments rated as high-performing (risk ratings 1 or 2).
-
Management expects to reduce net leverage, which rose to 1.44x, through a combination of organic NAV growth and utilizing scheduled or unscheduled repayment activity.
-
The company anticipates significant EBITDA improvement in 2026 for restructured holdings like 4-Wall Entertainment as film and TV production pipelines rebuild following industry strikes.
-
Strategic investments in David’s Bridal’s ‘Pearl’ digital marketplace are expected to expand the company’s reach into the broader $65-plus billion wedding services industry.
-
Management projects a reduction in PIK income over the next 12 to 18 months as several concentrated positions are expected to reach refinancing milestones.
-
The transition to monthly distributions starting in 2026 is intended to better align with shareholder expectations and provide more frequent capital returns.
-
NAV was impacted by what management calls the ‘COVID elongation cycle,’ where labor inflation and interest rate shocks delayed the recovery of restructured platforms like Avison Young and Juice Plus.
-
A new term loan, Healthway, was added to nonaccrual status following a restructuring that shifted value from the term loan to a newly funded revolver tranche.
-
The company strengthened its balance sheet by raising $307.5 million in unsecured debt, including a ‘baby bond’ offering subsequent to quarter-end, to replace maturing 2026 notes.
-
Share repurchases of approximately 556,000 shares at an average price of $9.37 were executed as an accretive use of capital given the discount to NAV.
